CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 22, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and immune-oncology, today...
Hence then, the article about harbour biomed reports the online publication of phase i results for hbm9378 skb378 win378 a tslp targeting antibody was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody )
Also on site :
- In 1957, Ford launched the Edsel after spending $250 million developing it; two years later Ford discontinued it, having lost $350 million
- Inde Navarrette Kicks Off ‘Saturday Night Live’ Debut With Shane Gillis Quip About Her “Little Whore Outfit” For Getting Into Marvel Shape
- ‘SNL’: Inde Navarrette Digs at Shane Gillis’ Joke About Women Dressing Like “Whores” at the Gym as Tom Hanks Crashes Cold Open